カテゴリー： QYResearch, 世界

世界の眼科用治療薬市場

◆英語タイトル：Global Ophthalmic Therapeutic Drugs Market Professional Survey Report 2019
◆商品コード：DATA909X12301
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：102
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、眼科用治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他に、用途別には、病院薬局、オンライン薬局、独立系薬局、ドラッグストアにセグメント区分し、眼科用治療薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・眼科用治療薬の世界市場概要
・眼科用治療薬の製造コスト構成分析
・眼科用治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・眼科用治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・眼科用治療薬のセグメント分析（種類別）
（抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他）
・眼科用治療薬のセグメント分析（用途別）
（病院薬局、オンライン薬局、独立系薬局、ドラッグストア）
・眼科用治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Bayer、Pfizer、Novartis、ALLERGAN、Aerie Pharmaceuticals、Valeant Pharmaceuticals International、Genentech、Regeneron Pharmaceuticals、Shire、Santen Pharmaceutical、）
・眼科用治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Ophthalmic Therapeutic Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Ophthalmic Therapeutic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ophthalmic Therapeutic Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ophthalmic Therapeutic Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ophthalmic Therapeutic Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bayer
Pfizer
Novartis
ALLERGAN
Aerie Pharmaceuticals
Valeant Pharmaceuticals International
Genentech
Regeneron Pharmaceuticals
Shire
Santen Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
by Therapeutic Class
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others
by Product Type
Prescription Drugs
Over-the-Counter Drugs

Segment by Application
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Ophthalmic Therapeutic Drugs
1.1 Definition of Ophthalmic Therapeutic Drugs
1.2 Ophthalmic Therapeutic Drugs Segment by Therapeutic Class
1.2.1 Global Ophthalmic Therapeutic Drugs Production Growth Rate Comparison by Therapeutic Class (2014-2025)
1.2.2 Anti-inflammatory Drugs
1.2.3 Anti-infective Drugs
1.2.4 Anti-glaucoma Drugs
1.2.5 Anti-allergy Drugs
1.2.6 Anti-VEGF Agents
1.2.7 Others
1.3 Ophthalmic Therapeutic Drugs Segment by Applications
1.3.1 Global Ophthalmic Therapeutic Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 Global Ophthalmic Therapeutic Drugs Overall Market
1.4.1 Global Ophthalmic Therapeutic Drugs Revenue (2014-2025)
1.4.2 Global Ophthalmic Therapeutic Drugs Production (2014-2025)
1.4.3 North America Ophthalmic Therapeutic Drugs Status and Prospect (2014-2025)
1.4.4 Europe Ophthalmic Therapeutic Drugs Status and Prospect (2014-2025)
1.4.5 China Ophthalmic Therapeutic Drugs Status and Prospect (2014-2025)
1.4.6 Japan Ophthalmic Therapeutic Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Ophthalmic Therapeutic Drugs Status and Prospect (2014-2025)
1.4.8 India Ophthalmic Therapeutic Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ophthalmic Therapeutic Drugs
2.3 Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs
2.4 Industry Chain Structure of Ophthalmic Therapeutic Drugs

3 Development and Manufacturing Plants Analysis of Ophthalmic Therapeutic Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Ophthalmic Therapeutic Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Ophthalmic Therapeutic Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Ophthalmic Therapeutic Drugs Production and Capacity Analysis
4.2 Ophthalmic Therapeutic Drugs Revenue Analysis
4.3 Ophthalmic Therapeutic Drugs Price Analysis
4.4 Market Concentration Degree

5 Ophthalmic Therapeutic Drugs Regional Market Analysis
5.1 Ophthalmic Therapeutic Drugs Production by Regions
5.1.1 Global Ophthalmic Therapeutic Drugs Production by Regions
5.1.2 Global Ophthalmic Therapeutic Drugs Revenue by Regions
5.2 Ophthalmic Therapeutic Drugs Consumption by Regions
5.3 North America Ophthalmic Therapeutic Drugs Market Analysis
5.3.1 North America Ophthalmic Therapeutic Drugs Production
5.3.2 North America Ophthalmic Therapeutic Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Ophthalmic Therapeutic Drugs Import and Export
5.4 Europe Ophthalmic Therapeutic Drugs Market Analysis
5.4.1 Europe Ophthalmic Therapeutic Drugs Production
5.4.2 Europe Ophthalmic Therapeutic Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Ophthalmic Therapeutic Drugs Import and Export
5.5 China Ophthalmic Therapeutic Drugs Market Analysis
5.5.1 China Ophthalmic Therapeutic Drugs Production
5.5.2 China Ophthalmic Therapeutic Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Ophthalmic Therapeutic Drugs Import and Export
5.6 Japan Ophthalmic Therapeutic Drugs Market Analysis
5.6.1 Japan Ophthalmic Therapeutic Drugs Production
5.6.2 Japan Ophthalmic Therapeutic Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Ophthalmic Therapeutic Drugs Import and Export
5.7 Southeast Asia Ophthalmic Therapeutic Drugs Market Analysis
5.7.1 Southeast Asia Ophthalmic Therapeutic Drugs Production
5.7.2 Southeast Asia Ophthalmic Therapeutic Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Ophthalmic Therapeutic Drugs Import and Export
5.8 India Ophthalmic Therapeutic Drugs Market Analysis
5.8.1 India Ophthalmic Therapeutic Drugs Production
5.8.2 India Ophthalmic Therapeutic Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Ophthalmic Therapeutic Drugs Import and Export

6 Ophthalmic Therapeutic Drugs Segment Market Analysis (by Type)
6.1 Global Ophthalmic Therapeutic Drugs Production by Type
6.2 Global Ophthalmic Therapeutic Drugs Revenue by Type
6.3 Ophthalmic Therapeutic Drugs Price by Type

7 Ophthalmic Therapeutic Drugs Segment Market Analysis (by Application)
7.1 Global Ophthalmic Therapeutic Drugs Consumption by Application
7.2 Global Ophthalmic Therapeutic Drugs Consumption Market Share by Application (2014-2019)

8 Ophthalmic Therapeutic Drugs Major Manufacturers Analysis
8.1 Bayer
8.1.1 Bayer Ophthalmic Therapeutic Drugs Production Sites and Area Served
8.1.2 Bayer Product Introduction, Application and Specification
8.1.3 Bayer Ophthalmic Therapeutic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Ophthalmic Therapeutic Drugs Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Ophthalmic Therapeutic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novartis
8.3.1 Novartis Ophthalmic Therapeutic Drugs Production Sites and Area Served
8.3.2 Novartis Product Introduction, Application and Specification
8.3.3 Novartis Ophthalmic Therapeutic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 ALLERGAN
8.4.1 ALLERGAN Ophthalmic Therapeutic Drugs Production Sites and Area Served
8.4.2 ALLERGAN Product Introduction, Application and Specification
8.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Aerie Pharmaceuticals
8.5.1 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Production Sites and Area Served
8.5.2 Aerie Pharmaceuticals Product Introduction, Application and Specification
8.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Valeant Pharmaceuticals International
8.6.1 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Production Sites and Area Served
8.6.2 Valeant Pharmaceuticals International Product Introduction, Application and Specification
8.6.3 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Genentech
8.7.1 Genentech Ophthalmic Therapeutic Drugs Production Sites and Area Served
8.7.2 Genentech Product Introduction, Application and Specification
8.7.3 Genentech Ophthalmic Therapeutic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Regeneron Pharmaceuticals
8.8.1 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Production Sites and Area Served
8.8.2 Regeneron Pharmaceuticals Product Introduction, Application and Specification
8.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Shire
8.9.1 Shire Ophthalmic Therapeutic Drugs Production Sites and Area Served
8.9.2 Shire Product Introduction, Application and Specification
8.9.3 Shire Ophthalmic Therapeutic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Santen Pharmaceutical
8.10.1 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Production Sites and Area Served
8.10.2 Santen Pharmaceutical Product Introduction, Application and Specification
8.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Ophthalmic Therapeutic Drugs Market
9.1 Global Ophthalmic Therapeutic Drugs Market Trend Analysis
9.1.1 Global Ophthalmic Therapeutic Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Ophthalmic Therapeutic Drugs Regional Market Trend
9.2.1 North America Ophthalmic Therapeutic Drugs Forecast 2019-2025
9.2.2 Europe Ophthalmic Therapeutic Drugs Forecast 2019-2025
9.2.3 China Ophthalmic Therapeutic Drugs Forecast 2019-2025
9.2.4 Japan Ophthalmic Therapeutic Drugs Forecast 2019-2025
9.2.5 Southeast Asia Ophthalmic Therapeutic Drugs Forecast 2019-2025
9.2.6 India Ophthalmic Therapeutic Drugs Forecast 2019-2025
9.3 Ophthalmic Therapeutic Drugs Market Trend (Product Type)
9.4 Ophthalmic Therapeutic Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Ophthalmic Therapeutic Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Ophthalmic Therapeutic Drugs
Table Global Ophthalmic Therapeutic Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Ophthalmic Therapeutic Drugs Production Market Share by Types in 2018
Figure Anti-inflammatory Drugs Product Picture
Figure Anti-infective Drugs Product Picture
Figure Anti-glaucoma Drugs Product Picture
Figure Anti-allergy Drugs Product Picture
Figure Anti-VEGF Agents Product Picture
Figure Others Product Picture
Table Global Ophthalmic Therapeutic Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Ophthalmic Therapeutic Drugs Consumption Market Share by Applications in 2018
Figure Hospital Pharmacies
Figure Online Pharmacies
Figure Independent Pharmacies & Drug Stores
Figure Global Ophthalmic Therapeutic Drugs Revenue (Million USD) (2014-2025)
Figure Global Ophthalmic Therapeutic Drugs Production (K Units) (2014-2025)
Figure North America Ophthalmic Therapeutic Drugs Market Size (Million USD) (2014-2025)
Figure Europe Ophthalmic Therapeutic Drugs Market Size (Million USD) (2014-2025)
Figure China Ophthalmic Therapeutic Drugs Market Size (Million USD) (2014-2025)
Figure Japan Ophthalmic Therapeutic Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Ophthalmic Therapeutic Drugs Market Size (Million USD) (2014-2025)
Figure India Ophthalmic Therapeutic Drugs Market Size (Million USD) (2014-2025)
Table Ophthalmic Therapeutic Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Ophthalmic Therapeutic Drugs in 2018
Figure Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs
Figure Industry Chain Structure of Ophthalmic Therapeutic Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Ophthalmic Therapeutic Drugs Manufacturing Plants Distribution
Table Ophthalmic Therapeutic Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Ophthalmic Therapeutic Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Ophthalmic Therapeutic Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Ophthalmic Therapeutic Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Ophthalmic Therapeutic Drugs Production Share by Manufacturers in 2018
Table Ophthalmic Therapeutic Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Ophthalmic Therapeutic Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Ophthalmic Therapeutic Drugs Revenue Share by Manufacturers in 2018
Table Ophthalmic Therapeutic Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Ophthalmic Therapeutic Drugs Production by Regions 2014-2019 (K Units)
Table Global Ophthalmic Therapeutic Drugs Production Market Share by Regions 2014-2019
Figure Global Ophthalmic Therapeutic Drugs Production Market Share by Regions in 2018
Table Global Ophthalmic Therapeutic Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Ophthalmic Therapeutic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Ophthalmic Therapeutic Drugs Revenue Market Share by Regions in 2018
Table Global Ophthalmic Therapeutic Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Ophthalmic Therapeutic Drugs Consumption Market Share by Regions 2014-2019
Figure North America Ophthalmic Therapeutic Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Ophthalmic Therapeutic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Ophthalmic Therapeutic Drugs Production, Consumption Import and Export (K Units)
Figure Europe Ophthalmic Therapeutic Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Ophthalmic Therapeutic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Ophthalmic Therapeutic Drugs Production, Consumption Import and Export (K Units)
Figure China Ophthalmic Therapeutic Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Ophthalmic Therapeutic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Ophthalmic Therapeutic Drugs Production, Consumption Import and Export (K Units)
Figure Japan Ophthalmic Therapeutic Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Ophthalmic Therapeutic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Ophthalmic Therapeutic Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Ophthalmic Therapeutic Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Ophthalmic Therapeutic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Ophthalmic Therapeutic Drugs Production, Consumption Import and Export (K Units)
Figure India Ophthalmic Therapeutic Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Ophthalmic Therapeutic Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Ophthalmic Therapeutic Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Ophthalmic Therapeutic Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Ophthalmic Therapeutic Drugs Market Share by Application (2014-2019)
Table Bayer Ophthalmic Therapeutic Drugs Production Sites and Area Served
Table Bayer Ophthalmic Therapeutic Drugs Product Introduction, Application and Specification
Table Bayer Ophthalmic Therapeutic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Ophthalmic Therapeutic Drugs Production Growth Rate (2014-2019)
Table Bayer Ophthalmic Therapeutic Drugs Production Market Share (2014-2019)
Figure Bayer Ophthalmic Therapeutic Drugs Revenue Market Share (2014-2019)
Table Bayer Ophthalmic Therapeutic Drugs Main Business and Markets Served
Table Pfizer Ophthalmic Therapeutic Drugs Production Sites and Area Served
Table Pfizer Ophthalmic Therapeutic Drugs Product Introduction, Application and Specification
Table Pfizer Ophthalmic Therapeutic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Ophthalmic Therapeutic Drugs Production Growth Rate (2014-2019)
Table Pfizer Ophthalmic Therapeutic Drugs Production Market Share (2014-2019)
Figure Pfizer Ophthalmic Therapeutic Drugs Revenue Market Share (2014-2019)
Table Pfizer Ophthalmic Therapeutic Drugs Main Business and Markets Served
Table Novartis Ophthalmic Therapeutic Drugs Production Sites and Area Served
Table Novartis Ophthalmic Therapeutic Drugs Product Introduction, Application and Specification
Table Novartis Ophthalmic Therapeutic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Ophthalmic Therapeutic Drugs Production Growth Rate (2014-2019)
Table Novartis Ophthalmic Therapeutic Drugs Production Market Share (2014-2019)
Figure Novartis Ophthalmic Therapeutic Drugs Revenue Market Share (2014-2019)
Table Novartis Ophthalmic Therapeutic Drugs Main Business and Markets Served
Table ALLERGAN Ophthalmic Therapeutic Drugs Production Sites and Area Served
Table ALLERGAN Ophthalmic Therapeutic Drugs Product Introduction, Application and Specification
Table ALLERGAN Ophthalmic Therapeutic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table ALLERGAN Ophthalmic Therapeutic Drugs Production Growth Rate (2014-2019)
Table ALLERGAN Ophthalmic Therapeutic Drugs Production Market Share (2014-2019)
Figure ALLERGAN Ophthalmic Therapeutic Drugs Revenue Market Share (2014-2019)
Table ALLERGAN Ophthalmic Therapeutic Drugs Main Business and Markets Served
Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Production Sites and Area Served
Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Product Introduction, Application and Specification
Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Production Growth Rate (2014-2019)
Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Production Market Share (2014-2019)
Figure Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Market Share (2014-2019)
Table Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Main Business and Markets Served
Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Production Sites and Area Served
Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Product Introduction, Application and Specification
Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Production Growth Rate (2014-2019)
Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Production Market Share (2014-2019)
Figure Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Revenue Market Share (2014-2019)
Table Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Main Business and Markets Served
Table Genentech Ophthalmic Therapeutic Drugs Production Sites and Area Served
Table Genentech Ophthalmic Therapeutic Drugs Product Introduction, Application and Specification
Table Genentech Ophthalmic Therapeutic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Genentech Ophthalmic Therapeutic Drugs Production Growth Rate (2014-2019)
Table Genentech Ophthalmic Therapeutic Drugs Production Market Share (2014-2019)
Figure Genentech Ophthalmic Therapeutic Drugs Revenue Market Share (2014-2019)
Table Genentech Ophthalmic Therapeutic Drugs Main Business and Markets Served
Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Production Sites and Area Served
Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Product Introduction, Application and Specification
Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Production Growth Rate (2014-2019)
Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Production Market Share (2014-2019)
Figure Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue Market Share (2014-2019)
Table Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Main Business and Markets Served
Table Shire Ophthalmic Therapeutic Drugs Production Sites and Area Served
Table Shire Ophthalmic Therapeutic Drugs Product Introduction, Application and Specification
Table Shire Ophthalmic Therapeutic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Shire Ophthalmic Therapeutic Drugs Production Growth Rate (2014-2019)
Table Shire Ophthalmic Therapeutic Drugs Production Market Share (2014-2019)
Figure Shire Ophthalmic Therapeutic Drugs Revenue Market Share (2014-2019)
Table Shire Ophthalmic Therapeutic Drugs Main Business and Markets Served
Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Production Sites and Area Served
Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Product Introduction, Application and Specification
Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Production Growth Rate (2014-2019)
Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Production Market Share (2014-2019)
Figure Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue Market Share (2014-2019)
Table Santen Pharmaceutical Ophthalmic Therapeutic Drugs Main Business and Markets Served
Figure Global Ophthalmic Therapeutic Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Ophthalmic Therapeutic Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Ophthalmic Therapeutic Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Ophthalmic Therapeutic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Ophthalmic Therapeutic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Ophthalmic Therapeutic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Ophthalmic Therapeutic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Ophthalmic Therapeutic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Ophthalmic Therapeutic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Ophthalmic Therapeutic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Ophthalmic Therapeutic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Ophthalmic Therapeutic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Ophthalmic Therapeutic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Ophthalmic Therapeutic Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Ophthalmic Therapeutic Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Ophthalmic Therapeutic Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Ophthalmic Therapeutic Drugs by Application (2019-2025)
Table Ophthalmic Therapeutic Drugs Distributors List
Table Ophthalmic Therapeutic Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Bayer、Pfizer、Novartis、ALLERGAN、Aerie Pharmaceuticals、Valeant Pharmaceuticals International、Genentech、Regeneron Pharmaceuticals、Shire、Santen Pharmaceutical、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の眼科用治療薬市場(Global Ophthalmic Therapeutic Drugs Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp